Naranjo Scale Calculator
How to Use This Tool
Answer the 10 yes/no questions about the adverse drug reaction. This tool calculates your score to determine if the reaction was definite, probable, possible, or doubtful.
Note: For questions where re-challenging (re-administering the drug) is not possible or ethical, select "Don't know" or skip where applicable.
Naranjo Scale Questions
Your Result
How to Interpret Your Score
- Definite 9+
- Probable 5-8
- Possible 1-4
- Doubtful 0 or lower
Note: This tool follows the original Naranjo Scale scoring system. For questions where re-challenging (re-administering the drug) is not possible or ethical, it's appropriate to select "Don't know" or skip as instructed.
When a patient gets sick after taking a new medication, how do you know if the drug actually caused it? It’s not always obvious. Maybe it was the flu. Maybe it was an old condition flaring up. Or maybe it really was the medicine. That’s where the Naranjo Scale comes in. It’s not fancy. It doesn’t need a computer. It’s just a simple 10-question checklist used by doctors, pharmacists, and nurses around the world to figure out if a bad reaction was really caused by a drug.
What Is the Naranjo Scale, Really?
The Naranjo Scale was created in 1981 by a team of researchers led by Dr. Carlos A. Naranjo. They built it because, after the thalidomide disaster in the 1960s, the world realized drug safety needed better rules. Before this scale, doctors guessed. Now, they have a system.
The scale asks 10 yes-or-no questions about the patient’s situation. Each answer gets a score: +1, +2, 0, or even -1. Add them all up, and you get a number. That number tells you how likely it is the drug caused the reaction.
It’s not magic. But it’s the most used tool for this job. In 2022, a study found it was used in 78% of published drug reaction reports - more than any other method. Hospitals, drug companies, and regulators like the FDA and the European Medicines Agency all use it as a starting point.
How the Scoring Works
Here’s how the 10 questions break down - no jargon, just what matters:
- Was the reaction reported before? If yes, +1 point. If not, 0.
- Did the reaction happen after the drug was taken? Timing matters. If it happened right after, +2. If it happened before, -1.
- Did the symptom get better when the drug was stopped? If yes, +1. If no change, 0.
- Did the reaction come back when the drug was given again? This is strong proof - +2 if yes. But here’s the catch: re-challenging a patient with a dangerous drug is often unethical. So most times, the answer is ‘don’t know’.
- Could something else have caused it? If yes, -1. If no, +2. This is the hardest question. A fever could be infection. Or it could be the drug. Clinicians often disagree here.
- Was a placebo used to test the reaction? +1 if yes. But in real life? Almost never. Giving a fake pill to someone who had a bad reaction? Not allowed anymore. So this question is mostly skipped.
- Was the drug level in the blood too high? If yes, +1. Only matters for drugs with known toxic levels, like digoxin or lithium.
- Did the reaction get worse with a higher dose? +1 if yes. This is common with drugs like warfarin or insulin.
- Has the patient had this reaction before with the same drug? +1 if yes. History matters.
- Is there objective proof? (Lab test, biopsy, etc.) +1 if yes. Blood tests showing liver damage? That’s solid evidence.
Add up the points:
- 9 or higher = Definite reaction
- 5 to 8 = Probable reaction
- 1 to 4 = Possible reaction
- 0 or lower = Doubtful
It’s simple. But not always easy. That’s why training matters.
Why It’s Still Used Today
You might think a 40-year-old tool is outdated. But here’s why it still holds up:
- It’s free and universal. No software needed. Just a paper form or a basic app.
- It forces structure. Without it, doctors rely on gut feeling. This tool makes them think step by step.
- It’s accepted globally. Over 75 countries use it in their official drug safety systems.
- It’s legally useful. If a patient sues over a side effect, a completed Naranjo Scale gives regulators and courts clear evidence.
Pharmacists at Massachusetts General Hospital told a Reddit thread: “We use it every day. It stops us from blaming the patient for their symptoms when it’s really the drug.”
Where It Falls Short
It’s not perfect. And here’s why experts are pushing for change:
- One drug at a time. Most elderly patients take 5-10 medications. The Naranjo Scale can’t tell which one caused the problem. For that, tools like the Liverpool Scale work better.
- Placebo question is outdated. Asking if a placebo caused the reaction? That’s not ethical anymore. Experts now suggest replacing it with a question about drug levels or monitoring data.
- No room for nuance. “Yes” or “no” doesn’t capture gray areas. A patient might have had a mild reaction before - was it the same? Maybe, maybe not. The scale doesn’t allow for “kind of.”
- Not built for modern drugs. Biologics, cancer immunotherapies, gene therapies - these work differently. Reactions can show up months later. The Naranjo Scale wasn’t designed for that.
One pharmacist from Johns Hopkins said: “We almost always mark ‘don’t know’ on rechallenge. So we’re stuck at ‘probable’ even when it’s clearly the drug.”
Digital Tools Are Making It Better
People aren’t just filling out paper forms anymore. A 2023 study showed that when healthcare workers used a simple Python app to calculate the Naranjo Score, they finished in 4.2 minutes - down from 11.3 minutes. Errors dropped from 28% to 9%.
Open-source tools like the Naranjo Calculator on GitHub let users plug in answers and get instant scores. Some hospital systems like Epic now auto-fill 4 of the 10 questions using patient data - like when the drug was given, or if liver enzymes spiked.
These aren’t replacing the scale. They’re just making it faster and more accurate.
Who Uses It - And Who Should Learn It
You won’t find the Naranjo Scale being used by your family doctor during a routine check-up. It’s mostly used in:
- Hospital pharmacovigilance teams
- Pharmaceutical safety departments
- Regulatory agencies reviewing drug reports
- Research studies on drug side effects
But if you’re a nurse, pharmacist, or med student - you should know it. A 2023 survey found nursing students mastered the scale after just 3-5 practice cases. Most people get comfortable after 20-30 assessments.
Training is simple. The Nebraska ASAP website offers a free worksheet. The International Society of Pharmacovigilance has a 27-page manual. Fiveable, an educational platform, has 12 real case studies used by over 15,000 students.
The Future of the Naranjo Scale
Will it be replaced? Probably not anytime soon.
AI tools like the FDA’s Sentinel Initiative are starting to predict drug reactions using big data. But they’re black boxes. You can’t see how they reached a conclusion. The Naranjo Scale? You can see every step. That’s why regulators still trust it.
In 2024, the International Council for Harmonisation proposed updating Question 6 - replacing the placebo question with a question about therapeutic drug monitoring. That’s a sign the tool is evolving, not dying.
Experts agree: it won’t be the only tool in 10 years. But it will still be the baseline. It’s the foundation. The first thing you check before you dig deeper.
Final Thought: It’s Not About Perfection - It’s About Consistency
The Naranjo Scale doesn’t give you the whole story. But it gives you a consistent story. And in drug safety, that’s everything.
When two doctors look at the same patient and both use the scale, they’ll usually agree on whether it’s probable or possible. That’s rare in medicine. Most of the time, opinions vary wildly.
That’s why, even in 2026, the Naranjo Scale still has a seat at the table. It doesn’t need AI. It doesn’t need fancy tech. It just needs someone who knows how to ask the right questions - and listen to the answers.
christian Espinola
January 18, 2026 AT 13:50The Naranjo Scale? More like the Naranjo Circus. They still use this 40-year-old paper checklist while AI can predict drug reactions from your Fitbit data. It’s not ‘reliable’-it’s a relic. They’re still asking about placebo tests like we’re in 1985. Wake up. This isn’t medicine-it’s paperwork theater.
Chuck Dickson
January 18, 2026 AT 20:26Actually, I think this is one of those beautiful, humble tools that still saves lives every day. You don’t need fancy tech to make someone think critically about causality. I’ve seen nurses use this to catch a dangerous interaction no algorithm would flag because the patient was ‘just getting older.’ Simple doesn’t mean useless-it means accessible. Keep it alive.
Dayanara Villafuerte
January 20, 2026 AT 00:04OMG I LOVE THIS. 🙌 Like, imagine a world where we actually stop blaming patients for their symptoms and start asking: ‘Did we just poison them?’ The Naranjo Scale is basically the medical version of ‘Did you touch the hot stove?’ before you scream ‘Why is my hand red?!’ 💉🔥 #PharmacistLife
Andrew Qu
January 21, 2026 AT 17:48For anyone learning this: start with the ‘could something else have caused it?’ question. That’s the one that trips people up. I used to think ‘fever = infection’ until I saw a patient get fever after starting vancomycin-and no other signs of infection. The scale forced me to look deeper. It’s not perfect, but it stops you from being lazy.
Jay Clarke
January 21, 2026 AT 21:22They’re still using this? Are you kidding me? The FDA’s AI system flagged 12,000 reactions last year that the Naranjo Scale missed because it couldn’t handle polypharmacy. This isn’t ‘foundational’-it’s a Band-Aid on a gunshot wound. Someone’s getting sued because a pharmacist checked ‘don’t know’ on rechallenge and called it ‘probable.’ That’s not safety. That’s liability roulette.
Selina Warren
January 22, 2026 AT 18:21Let’s be real-this scale is the last refuge of people who refuse to admit medicine is now data-driven. You want consistency? Fine. But consistency without accuracy is just repetition with a clipboard. The world moved on. We have machine learning models that analyze EHRs, genomics, and even social determinants. The Naranjo Scale is like using a slide rule to calculate rocket trajectories. Beautiful in theory. Useless in practice.
Robert Davis
January 23, 2026 AT 20:28I’ve used this tool for 18 years. I know it inside out. And I can tell you this: the biggest flaw isn’t the questions-it’s the people filling them out. Half the time, they guess. They don’t even check the chart. They just pick ‘probable’ because the family is yelling. The scale doesn’t fail. The humans do.
Eric Gebeke
January 23, 2026 AT 21:11Of course they still use it. Who else is going to protect Big Pharma? If you say a drug is ‘definite’ on this scale, the company has to report it. But if you say ‘possible’? They just bury it. This isn’t science-it’s a legal shield. The placebo question? That’s not outdated. It’s a loophole. They keep it so they can say, ‘We didn’t test it, so we don’t know.’
Jake Moore
January 24, 2026 AT 03:48Just ran a quick audit in our hospital. We used to take 12 minutes per case. Now with the GitHub calculator, it’s under 5. Errors dropped by 70%. The tool didn’t change. The interface did. This isn’t about replacing the Naranjo Scale-it’s about upgrading how we use it. Same logic, less typing. Win-win.
Max Sinclair
January 25, 2026 AT 05:48I appreciate the thoughtful breakdown here. The Naranjo Scale is far from perfect, but it creates a common language across disciplines. A nurse, pharmacist, and doctor can all look at the same score and agree on next steps. That’s huge in chaotic hospital environments. Maybe it’s not AI-powered, but it’s human-powered-and that matters.
Praseetha Pn
January 26, 2026 AT 21:13LOL you think this is bad? In India, they use this on patients who take 17 meds and 3 Ayurvedic tonics and 2 herbal teas from the temple priest. One guy got liver failure after ‘Neem juice’ and the doctor scored it ‘probable’ because the drug was given ‘after’ the tea. The tea wasn’t even in the database. This scale was built for one drug, one patient, one hospital. It’s a joke in the real world.
Nishant Sonuley
January 28, 2026 AT 09:03Let’s not forget that this scale was born out of the thalidomide tragedy-a time when we didn’t know how to track harm. Today, we have real-time global databases, pharmacogenomic profiles, and AI-driven signal detection. But we still cling to this because it feels like control. We like the illusion of structure, even when it’s broken. It’s not about the tool-it’s about our fear of uncertainty. We’d rather be wrong together than right alone.
Emma #########
January 29, 2026 AT 07:10I used to hate this scale. Thought it was too rigid. But after I saw a patient recover within 48 hours of stopping a drug they’d been on for months-just because we used Naranjo to confirm it was probable-I changed my mind. Sometimes, it’s not about being perfect. It’s about being brave enough to say: ‘Maybe we did this.’
Andrew McLarren
January 29, 2026 AT 08:38While the Naranjo Scale undoubtedly possesses certain methodological limitations, its enduring utility lies in its standardized, reproducible framework, which mitigates cognitive bias in pharmacovigilance reporting. The absence of digital integration does not constitute obsolescence; rather, it underscores the importance of human clinical judgment as the primary arbiter of causality in complex, heterogeneous patient populations.